Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Ruth Kempf

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Analytical Biochemistry|September 26, 2008
Single-cell research: what determines its feasibility?Alex Sabelnikov, C Ruth Kempf
International Journal of Environmental Health Research|July 21, 2006
Airborne exposure limits for chemical and biological warfare agents: is everything set and clear?Alex Sabelnikov, Vladimir Zhukov, C Ruth Kempf
Advances in Enzyme Regulation|November 2, 2010
Targeting the cancer initiating cell: the Achilles' heel of cancerJames A McCubrey, William H Chappell, Stephen L Abrams, et al.
Journal of Cellular Physiology|February 9, 2011
Therapeutic resistance resulting from mutations in Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR signaling pathwaysJames A McCubrey, Linda S Steelman, C Ruth Kempf, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Analytical Biochemistry|September 26, 2008
Single-cell research: what determines its feasibility?Alex Sabelnikov, C Ruth Kempf
International Journal of Environmental Health Research|July 21, 2006
Airborne exposure limits for chemical and biological warfare agents: is everything set and clear?Alex Sabelnikov, Vladimir Zhukov, C Ruth Kempf
Advances in Enzyme Regulation|November 2, 2010
Targeting the cancer initiating cell: the Achilles' heel of cancerJames A McCubrey, William H Chappell, Stephen L Abrams, et al.
Journal of Cellular Physiology|February 9, 2011
Therapeutic resistance resulting from mutations in Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR signaling pathwaysJames A McCubrey, Linda S Steelman, C Ruth Kempf, et al.
Pageof 1